6:13 PM
 | 
May 08, 2008
 |  BC Extra  |  Company News

Osiris selling Osteocel

Osiris (NASDAQ:OSIR) agreed to sell its Osteocel business to NuVasive (NASDAQ:NUVA) for $35 million in cash, plus $50 million in milestones. Osiris also will supply NuVasive with Osteocel for up to 18 months...

Read the full 153 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >